134 related articles for article (PubMed ID: 20925460)
1. Thymidine kinase gene modified bone marrow mesenchymal stem cells as vehicles for antitumor therapy.
Song C; Xiang J; Tang J; Hirst DG; Zhou J; Chan KM; Li G
Hum Gene Ther; 2011 Apr; 22(4):439-49. PubMed ID: 20925460
[TBL] [Abstract][Full Text] [Related]
2. The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cells.
Huang Q; Liu XZ; Kang CS; Wang GX; Zhong Y; Pu PY
Cancer Gene Ther; 2010 Mar; 17(3):192-202. PubMed ID: 19851353
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
4. TK-GFP fusion gene virus vectors as tools for studying the features of HSV-TK/ganciclovir cancer gene therapy in vivo.
Pasanen T; Hakkarainen T; Timonen P; Parkkinen J; Tenhunen A; Loimas S; Wahlfors J
Int J Mol Med; 2003 Oct; 12(4):525-31. PubMed ID: 12964030
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus-mediated gene transfer of enhanced Herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing.
Wiewrodt R; Amin K; Kiefer M; Jovanovic VP; Kapoor V; Force S; Chang M; Lanuti M; Black ME; Kaiser LR; Albelda SM
Cancer Gene Ther; 2003 May; 10(5):353-64. PubMed ID: 12719705
[TBL] [Abstract][Full Text] [Related]
7. HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells.
Matuskova M; Hlubinova K; Pastorakova A; Hunakova L; Altanerova V; Altaner C; Kucerova L
Cancer Lett; 2010 Apr; 290(1):58-67. PubMed ID: 19765892
[TBL] [Abstract][Full Text] [Related]
8. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
9. A gene delivery system with a human artificial chromosome vector based on migration of mesenchymal stem cells towards human glioblastoma HTB14 cells.
Kinoshita Y; Kamitani H; Mamun MH; Wasita B; Kazuki Y; Hiratsuka M; Oshimura M; Watanabe T
Neurol Res; 2010 May; 32(4):429-37. PubMed ID: 19589205
[TBL] [Abstract][Full Text] [Related]
10. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.
Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW
Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756
[TBL] [Abstract][Full Text] [Related]
11. Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection.
Zhang TY; Huang B; Yuan ZY; Hu YL; Tabata Y; Gao JQ
Nanomedicine; 2014 Jan; 10(1):257-67. PubMed ID: 23770065
[TBL] [Abstract][Full Text] [Related]
12. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912
[TBL] [Abstract][Full Text] [Related]
13. Retrovirus-mediated gene therapy of experimental brain neoplasms using the herpes simplex virus-thymidine kinase/ganciclovir paradigm.
Rainov NG; Kramm CM; Aboody-Guterman K; Chase M; Ueki K; Louis DN; Harsh GR; Chiocca A; Breakefield XO
Cancer Gene Ther; 1996; 3(2):99-106. PubMed ID: 8729908
[TBL] [Abstract][Full Text] [Related]
14. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
15. Synergy between the herpes simplex virus tk/ganciclovir prodrug suicide system and the topoisomerase I inhibitor topotecan.
Wildner O; Blaese RM; Morris JC
Hum Gene Ther; 1999 Nov; 10(16):2679-87. PubMed ID: 10566896
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
[TBL] [Abstract][Full Text] [Related]
17. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity.
Wildner O; Morris JC
Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625
[TBL] [Abstract][Full Text] [Related]
18. Bystander effect in glioma suicide gene therapy using bone marrow stromal cells.
Li S; Gu C; Gao Y; Amano S; Koizumi S; Tokuyama T; Namba H
Stem Cell Res; 2012 Nov; 9(3):270-6. PubMed ID: 23022734
[TBL] [Abstract][Full Text] [Related]
19. Neural stem cell-based dual suicide gene delivery for metastatic brain tumors.
Wang C; Natsume A; Lee HJ; Motomura K; Nishimira Y; Ohno M; Ito M; Kinjo S; Momota H; Iwami K; Ohka F; Wakabayashi T; Kim SU
Cancer Gene Ther; 2012 Nov; 19(11):796-801. PubMed ID: 23018623
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus thymidine kinase gene transduction enhances tumor growth rate and cyclooxygenase-2 expression in murine colon cancer cells.
Konson A; Ben-Kasus T; Mahajna JA; Danon A; Rimon G; Agbaria R
Cancer Gene Ther; 2004 Dec; 11(12):830-40. PubMed ID: 15359292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
